Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial.
Vibeke StrandEduardo MyslerRobert John MootsGene V WallensteinRyan DeMasiDavid GrubenKoshika SomaNoriko IikuniJosef S SmolenRoy M FleischmannPublished in: RMD open (2019)
NCT02187055.